United States · Series D startup

Who invested in Emalex Biosciences

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$270Mraised across 1 round since 2022, from 1 source

Latest round
Series D, $270MNov 2022
Investors
3
See who backed them

The rounds

  1. Nov 2022

Everyone who backed them

FidelityVC firm1round
Bain Capital Life SciencesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Emalex Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Horizon Technology FinanceVenture debtPer its own site

Quick answers about Emalex Biosciences

Who invested in Emalex Biosciences?

Emalex Biosciences's investors include Fidelity, Valor Equity Partners and Bain Capital Life Sciences.

How much has Emalex Biosciences raised?

Emalex Biosciences has raised $270M across 1 round since 2022.

When did Emalex Biosciences last raise?

Emalex Biosciences's most recent round was a Series D of $270M in Nov 2022.

What was Emalex Biosciences's biggest round?

Its most recent round, $270M in Nov 2022, is also its largest on record.

Who backed Emalex Biosciences first?

Emalex Biosciences's first round on record, in Nov 2022, was backed by Fidelity, Valor Equity Partners and Bain Capital Life Sciences.

What stage is Emalex Biosciences at?

Emalex Biosciences's latest named round is a Series D, in Nov 2022.

Where is Emalex Biosciences based?

Emalex Biosciences is based in the United States.

Companies like Emalex Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.